The clinivation Global xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global xi liberates revenue that's trapped-in-process.

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition.

Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems, Inc. in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry.

With more than 50,000 products used by more than 75,000 customers around the globe, Life Technologies is advancing scientific research in areas like academic research, drug discovery and development, toxicology and forensics, disease diagnostics, clinical cell therapy and regenerative medicine, and biologics manufacturing.

For more information, please visit www.lifetechnologies.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.